Articles Tagged With:
-
FDA Adopts Flu-Like Plan for an Annual COVID Vaccine
The Food and Drug Administration took a decisive step recently in pivoting to fight COVID-19 with an approach similar to that used for decades against influenza, a seasonal virus for which a vaccine is concocted annually based on the circulating strains.
-
Complications of Permanent Pacemakers in the Emergency Department Setting
Given the prevalence of cardiac implantable electronic devices in emergency department populations, it is critical to be aware of the relative risk and variety of complications related to these devices so that proper workup and treatment can be initiated.
-
American Academy of Pediatrics Offers Solutions to Ease ED Crowding
Group says “coordinated effort across the healthcare delivery system” needed to ensure continuity of care.
-
Financial Coaching Boosts Follow-Up Visit, Vaccination Rates for Babies
Assisting low-income new parents can lead to better outcomes.
-
Legal Landmines for Patients Referred to ED for Psychiatric Evaluation
These risks relate to information-sharing for care coordination and continuity of care.
-
‘Medical Clearance’ of Psychiatric Patient Can be Legally Risky
What does "medical clearance" really mean? Does it indicate a patient has no acute issues, or that all the patient’s chronic issues are stable? Or is it both? The answer depends on who you ask.
-
Asymptomatic with Inverted T Waves
The ECG in the figure is from a healthy young adult without symptoms. Clinicians recorded this tracing as part of the patient’s employment physical exam. Is the T wave inversion likely to be a normal variant?
-
Daprodustat (Jesduvroq)
Daprodustat can be prescribed to treat anemia caused by chronic kidney disease in adults who have been receiving dialysis for at least four months.
-
Does Surviving an ECMO Stay Put Patients at Greater Risk for Mental Health Problems?
Survivors of extracorporeal membrane oxygenation (ECMO) demonstrated a modest increase in risk of new mental health diagnoses after discharge vs. ICU survivors who do not undergo ECMO.
-
Can a Blood-Based Test Serve as a Biomarker for Parkinson’s Disease?
The authors of this proof-of-concept study proposed that a noninvasive assay detecting pathology-associated α-synuclein extracted from blood may reveal a reliable biomarker for Parkinson’s disease.